Company
ConvaTec Group PLC
LON:CTEC
ConvaTec is a global medical products and technologies company, with leading market positions in ostomy care, wound therapeutics, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Our brands include AQUACEL® advanced wound dressings, which form a gel on contact with wound fluid, creating an optimal environment for wound healing. ConvaTec has over 8,000 employees, with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners.
83 stories · page 1 of 5
Hardware & electrical equipment
FTSE reshuffle confirmed with investment trusts on the rise, while Cineworld and Made.com drop out of All-Share
Asset manager Abrdn, Howden Joinery and genetic medicines maker Hikma were all relegated from London's top-flight index into the FTSE 250
ConvaTec: Wall Street bank thinks you may bag a bargain
JP Morgan believes margin concerns may be a tad overdone
ConvaTec's caveats, issues and margin troubles lead to downgrade from RBC Capital
Higher input costs and freight costs are not able to be passed on to customers in the near-term, "and it is not clear about the mid-term either"
ConvaTec turnaround worries unfounded, says broker
Analysts at Peel Hunt said the medical products firm had beaten expectations in its first-half results last August and again in its third quarter, while also delivering strong numbers in its final results and in the first quarter of the cur
ConvaTec keeps dividend as it expects full-year revenue growth
Revenue is expected to rise by 2-3.5% in the year to December
ConvaTec higher as it maintains 2020 outlook and dividend but warns of increased risk from coronavirus
The FTSE 250 medical equipment maker also reported a "robust" first quarter with revenues up 6.9% at US$460mln